Table of Content

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biopharmaceuticals Contract Manufacturing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary
2.1 Emerging Outsourcing Trends in Biopharmaceuticals
2.2 Demand for RNA-based COVID-19 Vaccines Creates Revenue Opportunities for Contact Manufacturers
2.3 Increase in Investment in Research & Development
2.4 Analyst Viewpoint

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rise in Investment by CMOs for Capacity Expansion
3.2.1.2 Cost and Time Saving Benefits Offered by Contract Services
3.2.1.3 Outsourcing as a Driver for Market Growth
3.2.1.4 Growing Investments in Orphan Drugs
3.2.2 Market Restraining Factors
3.2.2.1 Pricing Pressure to Impede Market Growth
3.2.2.2 Regulatory Scenarios
3.2.2.3 Overcapacity Likely to Challenge Market Growth
3.2.3 Market Opportunities
3.2.3.1 Expansion of Fill and Finish CMOs
3.2.3.2 Emergence of Single-Use Bioprocessing Equipment & Solutions
3.2.3.3 Emerging Economies to Offer Lucrative Growth Opportunities
3.3 COVID-19 Impact Analysis
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weaknesses
3.4.3 Opportunities
3.4.4 Threats
3.5 Porter’s Five Forces Analysis
3.5.1 Buyer Power
3.5.2 Supplier Power
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitute
3.5.5 Threat of New Entrants
3.6 PEST Analysis
3.6.1 Political Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.6.2 Economic Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.6.3 Social Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.6.4 Technological Factors Impacting Biopharmaceuticals Contract Manufacturing Market

4 Biopharmaceuticals Contract Manufacturing Market Analysis by Source
4.1 Key Findings
4.2 Source Segment: Market Attractiveness Index
4.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
4.4 Mammalian
4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Non-mammalian
4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Biopharmaceuticals Contract Manufacturing Market Analysis by Service
5.1 Key Findings
5.2 Service Segment: Market Attractiveness Index
5.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
5.4 Process Development
5.4.1 Upstream Process Development
5.4.2 Downstream Process Development
5.4.3 Market Forecast by Region, 2023-2033 (US$ Mn)
5.4.4 Market Share by Region, 2023 & 2033 (%)
5.4.4.1 Market Forecast by Type, 2023-2033 (US$ Mn)
5.5 Fill & Finish Operations
5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Analytical & QC Studies
5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Packaging
5.7.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.7.2 Market Share by Region, 2023 & 2033 (%)

6 Biopharmaceuticals Contract Manufacturing Market Analysis by Product
6.1 Key Findings
6.2 Product Segment: Market Attractiveness Index
6.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
6.4 Biologics
6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.4.2.1 Market Forecast by Type, 2023-2033 (US$ Mn)
6.5 Biosimilars
6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
6.5.2 Market Share by Region, 2023 & 2033 (%)

7 Biopharmaceuticals Contract Manufacturing Market Analysis by Scale of Operation
7.1 Key Findings
7.2 Scale of Operation Segment: Market Attractiveness Index
7.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operation
7.4 Preclinical
7.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Clinical
7.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Commercial
7.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
7.6.2 Market Share by Region, 2023 & 2033 (%)

8 Biopharmaceuticals Contract Manufacturing Market Analysis by Company Size
8.1 Key Findings
8.2 Company Size Segment: Market Attractiveness Index
8.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
8.4 Small
8.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
8.4.2 Market Share by Region, 2023 & 2033 (%)
8.5 Mid-sized
8.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
8.5.2 Market Share by Region, 2023 & 2033 (%)
8.6 Large
8.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
8.6.2 Market Share by Region, 2023 & 2033 (%)

9 Biopharmaceuticals Contract Manufacturing Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America Biopharmaceuticals Contract Manufacturing Market Analysis
10.1 Key Findings
10.2 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
10.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn)
10.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn)
10.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn)
10.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn)
10.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn)
10.10 U.S. Biopharmaceuticals Contract Manufacturing Market Analysis
10.11 Canada Biopharmaceuticals Contract Manufacturing Market Analysis

11 Europe Biopharmaceuticals Contract Manufacturing Market Analysis
11.1 Key Findings
11.2 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
11.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn)
11.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn)
11.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn)
11.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn)
11.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn)
11.10 Germany Biopharmaceuticals Contract Manufacturing Market Analysis
11.11 UK Biopharmaceuticals Contract Manufacturing Market Analysis
11.12 France Biopharmaceuticals Contract Manufacturing Market Analysis
11.13 Italy Biopharmaceuticals Contract Manufacturing Market Analysis
11.13.1 Role of CDMO Business Across Italy
11.13.2 Investment by Major Players to Fuel Market Expansion
11.14 Spain Biopharmaceuticals Contract Manufacturing Market Analysis
11.15 Russia Biopharmaceuticals Contract Manufacturing Market Analysis
11.16 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Analysis

12 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis
12.1 Key Findings
12.2 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
12.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn)
12.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn)
12.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn)
12.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn)
12.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn)
12.10 Japan Biopharmaceuticals Contract Manufacturing Market Analysis
12.11 China Biopharmaceuticals Contract Manufacturing Market Analysis
12.12 India Biopharmaceuticals Contract Manufacturing Market Analysis
12.12.1 The COVID-19 pandemic has brought India’s biotechnology industry, especially biopharmaceuticals into the limelight
12.12.2 Piramal Pharma Ltd. Invests Minority Stake in CDMO Yapan Bio
12.12.3 Stelis Biopharma Limited Receives EU-GMP for Two of its Manufacturing Facilities
12.13 Australia Biopharmaceuticals Contract Manufacturing Market Analysis
12.14 South-East Asia Biopharmaceuticals Contract Manufacturing Market Analysis
12.15 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis

13 Latin America Biopharmaceuticals Contract Manufacturing Market Analysis
13.1 Key Findings
13.2 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
13.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
13.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn)
13.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn)
13.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn)
13.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn)
13.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn)
13.10 Brazil Biopharmaceuticals Contract Manufacturing Market Analysis
13.11 Mexico Biopharmaceuticals Contract Manufacturing Market Analysis
13.12 Argentina Biopharmaceuticals Contract Manufacturing Market Analysis
13.13 Colombia Biopharmaceuticals Contract Manufacturing Market Analysis
13.14 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Analysis

14 MEA Biopharmaceuticals Contract Manufacturing Market Analysis
14.1 Key Findings
14.2 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
14.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
14.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
14.5 Market Size Estimation and Forecast by Source, 2023-2033 (US$ Mn)
14.6 Market Size Estimation and Forecast by Service, 2023-2033 (US$ Mn)
14.7 Market Size Estimation and Forecast by Product, 2023-2033 (US$ Mn)
14.8 Market Size Estimation and Forecast by Scale of Operation, 2023-2033 (US$ Mn)
14.9 Market Size Estimation and Forecast by Company Size, 2023-2033 (US$ Mn)
14.10 GCC Biopharmaceuticals Contract Manufacturing Market Analysis
14.11 South Africa Biopharmaceuticals Contract Manufacturing Market Analysis
14.12 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Analysis

15 Company Profiles
15.1 AbbVie, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.3.1 Net Revenue, 2015-2022
15.1.3.2 R&D Expenses, 2015-2022
15.1.3.3 Regional Market Shares, 2022
15.1.4 Service Benchmarking
15.1.5 Strategic Outlook
15.2 AGC Biologics
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Service Benchmarking
15.2.4 Strategic Outlook
15.3 Avantor, Inc.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2022
15.3.3.2 Regional Market Shares, 2021
15.3.4 Service Benchmarking
15.3.5 Strategic Outlook
15.4 Binex Co., Ltd.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Service Benchmarking
15.5 Boehringer Ingelheim GmbH
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2015-2021
15.5.4 Service Benchmarking
15.5.5 Strategic Outlook
15.6 FUJIFILM Diosynth Biotechnologies
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Service Benchmarking
15.6.4 Strategic Outlook
15.7 Lonza
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2015-2022
15.7.3.2 R&D Expenses, 2017-2021
15.7.4 Service Benchmarking
15.7.5 Strategic Outlook
15.8 ProBioGen
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Service Benchmarking
15.8.4 Strategic Outlook
15.9 Rentschler Biopharma SE
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Service Benchmarking
15.9.4 Strategic Outlook
15.10 Samsung Biologics
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Service Benchmarking
15.10.4 Strategic Outlook
15.11 Sandoz
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2015-2022
15.11.3.2 Regional Market Shares, 2021
15.11.4 Service Benchmarking
15.11.5 Strategic Outlook
15.12 TOYOBO CO., LTD.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Service Benchmarking
15.13 WuXi Biologics
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2015-2022
15.13.3.2 Regional Market Shares, 2022
15.13.4 Service Benchmarking
15.13.5 Strategic Outlook
15.14 JRS PHARMA
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Service Benchmarking
15.14.4 Strategic Outlook
15.15 Thermo Fisher Scientific
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2015-2022
15.15.3.2 R&D, 2015-2022
15.15.3.3 Regional Market Shares, 2022
15.15.4 Service Benchmarking
15.16 Cambrex Corporation
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Service Benchmarking
15.16.4 Strategic Outlook
15.17 Curia Global, Inc.
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Service Benchmarking
15.17.4 Strategic Outlook
15.18 Pfizer CentreOne
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2015-2022
15.18.3.2 R&D, 2015-2022
15.18.3.3 Regional Market Shares, 2022
15.18.4 Service Benchmarking
15.19 Jubilant Pharma Limited
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Service Benchmarking
15.20 Catalent, Inc
15.20.1 Company Snapshot
15.20.2 Company Overview
15.20.3 Financial Analysis
15.20.3.1 Net Revenue, 2015-2022
15.20.4 Service Benchmarking
15.20.5 Strategic Outlook
15.21 KBI Biopharma
15.21.1 Company Snapshot
15.21.2 Company Overview
15.21.3 Service Benchmarking
15.21.4 Strategic Outlook
15.22 Cytiva
15.22.1 Company Snapshot
15.22.2 Company Overview
15.22.3 Service Benchmarking
15.22.4 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 Biopharmaceuticals Contract Manufacturing Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Mammalian Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 8 Non-mammalian Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 9 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Process Development Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 Biopharmaceuticals Contract Manufacturing Market Forecast by Process Development, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 12 Fill & Finish Operations Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 13 Analytical & QC Studies Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 14 Packaging Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 15 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Biologics Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 17 Biopharmaceuticals Contract Manufacturing Market Forecast by Application, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 18 Biosimilars Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 19 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 20 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 21 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 22 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Small Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 24 Mid-sized Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 25 Large Segment Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 26 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Russia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 South-East Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 Colombia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 78 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 79 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 80 AbbVie, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 AbbVie, Inc.: Service Benchmarking
Table 82 AbbVie, Inc.: Strategic Outlook
Table 83 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 AGC Biologics: Service Benchmarking
Table 85 AGC Biologics: Strategic Outlook
Table 86 Avantor, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Avantor, Inc.: Service Benchmarking
Table 88 Avantor, Inc.: Strategic Outlook
Table 89 Binex Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Binex Co., Ltd.: Service Benchmarking
Table 91 Boehringer Ingelheim GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Boehringer Ingelheim GmbH: Service Benchmarking
Table 93 Boehringer Ingelheim GmbH: Strategic Outlook
Table 94 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
Table 96 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
Table 97 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Lonza: Service Benchmarking
Table 99 Lonza: Strategic Outlook
Table 100 ProBioGen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 ProBioGen: Service Benchmarking
Table 102 ProBioGen: Strategic Outlook
Table 103 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Rentschler Biopharma SE: Service Benchmarking
Table 105 Rentschler Biopharma SE: Strategic Outlook
Table 106 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Samsung Biologics: Service Benchmarking
Table 108 Samsung Biologics: Strategic Outlook
Table 109 Sandoz: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Sandoz: Service Benchmarking
Table 111 Sandoz: Strategic Outlook
Table 112 TOYOBO CO., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 TOYOBO CO., LTD.: Service Benchmarking
Table 114 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 WuXi Biologics: Service Benchmarking
Table 116 WuXi Biologics: Strategic Outlook
Table 117 JRS PHARMA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 JRS PHARMA: Service Benchmarking
Table 119 JRS PHARMA: Strategic Outlook
Table 120 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Thermo Fisher Scientific: Service Benchmarking
Table 122 Cambrex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 123 Cambrex Corporation: Service Benchmarking
Table 124 Cambrex Corporation: Strategic Outlook
Table 125 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 126 Curia Global, Inc.: Service Benchmarking
Table 127 Curia Global, Inc.: Strategic Outlook
Table 128 Pfizer CentreOne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Pfizer CentreOne: Service Benchmarking
Table 130 Jubilant Pharma Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 Jubilant Pharma Limited: Service Benchmarking
Table 132 Catalent, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Catalent, Inc: Service Benchmarking
Table 134 Catalent, Inc: Strategic Outlook
Table 135 KBI Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 KBI Biopharma: Service Benchmarking
Table 137 KBI Biopharma: Strategic Outlook
Table 138 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Cytiva: Service Benchmarking
Table 140 Cytiva: Strategic Outlook

List of Figures
Figure 1 Biopharmaceuticals Contract Manufacturing Market Segmentation
Figure 2 Biopharmaceuticals Contract Manufacturing Market: Market Dynamics
Figure 3 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 4 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 5 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 6 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 7 SWOT Analysis
Figure 8 Porter’s Five Forces Analysis
Figure 9 PEST Analysis
Figure 10 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
Figure 11 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %)
Figure 12 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023, 2028, 2033 (%)
Figure 13 Mammalian Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 14 Mammalian Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 15 Non-mammalian Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 16 Non-mammalian Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
Figure 18 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %)
Figure 19 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023, 2028, 2033 (%)
Figure 20 Process Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 21 Process Development Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 Process Development Segment Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 23 Fill & Finish Operations Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Fill & Finish Operations Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Analytical & QC Studies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Analytical & QC Studies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Packaging Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Packaging Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Product
Figure 30 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 31 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023, 2028, 2033 (%)
Figure 32 Biologics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Biologics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Biologics Segment Market Forecast by Type, 2023-2033 (US$ Million, AGR %)
Figure 35 Biosimilars Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 36 Biosimilars Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Scale of Operation
Figure 38 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
Figure 39 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023, 2028, 2033 (%)
Figure 40 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 41 Preclinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 42 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 43 Clinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 44 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 45 Commercial Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 46 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Company Size
Figure 47 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
Figure 48 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023, 2028, 2033 (%)
Figure 49 Small Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Small Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Mid-sized Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 52 Mid-sized Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Large Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 54 Large Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 55 Biopharmaceuticals Contract Manufacturing Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 56 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 57 Biopharmaceuticals Contract Manufacturing Market by Region, 2023-2033 (US$ Mn)
Figure 58 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 59 North America Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 60 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 61 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 62 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %)
Figure 63 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%)
Figure 64 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %)
Figure 65 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%)
Figure 66 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 67 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%)
Figure 68 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
Figure 69 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
Figure 70 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
Figure 71 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 72 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 73 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 74 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 75 Europe Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 76 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %)
Figure 78 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%)
Figure 79 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %)
Figure 80 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%)
Figure 81 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 82 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%)
Figure 83 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
Figure 84 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
Figure 85 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
Figure 86 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 87 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 88 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 89 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 90 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 91 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 92 Russia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 93 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 94 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 95 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 96 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 97 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 98 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %)
Figure 99 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%)
Figure 100 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %)
Figure 101 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%)
Figure 102 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 103 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%)
Figure 104 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
Figure 105 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
Figure 106 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
Figure 107 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 108 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 109 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 110 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 111 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 112 South-East Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 113 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 114 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 115 Latin America Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 116 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 117 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %)
Figure 118 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%)
Figure 119 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %)
Figure 120 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%)
Figure 121 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 122 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%)
Figure 123 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
Figure 124 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
Figure 125 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
Figure 126 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 127 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 128 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 129 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 130 Colombia Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 131 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 132 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 133 MEA Biopharmaceuticals Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 134 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 136 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2023-2033 (US$ Million, AGR %)
Figure 137 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2023 & 2033 (%)
Figure 138 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2023-2033 (US$ Million, AGR %)
Figure 139 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2023 & 2033 (%)
Figure 140 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2023-2033 (US$ Million, AGR %)
Figure 141 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2023 & 2033 (%)
Figure 142 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2023-2033 (US$ Million, AGR %)
Figure 143 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operation, 2023 & 2033 (%)
Figure 144 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
Figure 145 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%)
Figure 146 GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 147 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 148 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 149 AbbVie, Inc.: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 150 AbbVie, Inc.: R&D Expenses, 2015-2022 (US$ million, AGR%)
Figure 151 AbbVie, Inc.: Regional Market Shares, 2022 (%)
Figure 152 Avantor, Inc.: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 153 Avantor, Inc.: Regional Market Share (AGR%)
Figure 154 Boehringer Ingelheim GmbH: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 155 Lonza: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 156 Lonza: R&D Expenses, 2017-2021 (US$ million, AGR%)
Figure 157 Sandoz: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 158 Sandoz: Regional Market Share (AGR%)
Figure 159 WuXi Biologics: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 160 WuXi Biologics: Regional Market Shares, 2022 (%)
Figure 161 Thermo Fisher Scientific: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 162 Thermo Fisher Scientific: R&D, 2015-2022 (US$ million, AGR%)
Figure 163 Thermo Fisher Scientific: Regional Market Shares, 2022 (%)
Figure 164 Pfizer CentreOne: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 165 Pfizer CentreOne: R&D, 2015-2022 (US$ million, AGR%)
Figure 166 Pfizer CentreOne: Regional Market Shares, 2022 (%)
Figure 167 Catalent, Inc: Net Revenue, 2015-2022 (US$ million, AGR%)